Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases. | RNA Biol | 2022 | 35354425 | PubTator, text mining | PubMed |
| mRNA cancer vaccines: Advances, trends and challenges. | Acta Pharm Sin B | 2022 | 35345451 | PubTator, text mining | PubMed |
| Engineering the T cell receptor for fun and profit: Uncovering complex biology, interrogating the immune system, and targeting disease. | Curr Opin Struct Biol | 2022 | 35344834 | PubTator, text mining | PubMed |
| Advanced Biomaterials for Cell-Specific Modulation and Restore of Cancer Immunotherapy. | Adv Sci (Weinh) | 2022 | 35343112 | PubTator, text mining | PubMed |
| Development of Peptide-Based Vaccines for Cancer. | J Oncol | 2022 | 35342400 | PubTator, text mining | PubMed |
| Delivery of mRNA for regulating functions of immune cells. | J Control Release | 2022 | 35337940 | PubTator, text mining | PubMed |
| Nonviral Delivery Systems of mRNA Vaccines for Cancer Gene Therapy. | Pharmaceutics | 2022 | 35335891 | PubTator, text mining | PubMed |
| Genetic Modification of T Cells for the Immunotherapy of Cancer. | Vaccines (Basel) | 2022 | 35335089 | PubTator, text mining | PubMed |
| Current Status and Future Directions of Immunotherapies in Soft Tissue Sarcomas. | Biomedicines | 2022 | 35327375 | PubTator, text mining | PubMed |
| Advances in COVID-19 mRNA vaccine development. | Signal Transduct Target Ther | 2022 | 35322018 | PubTator, text mining | PubMed |
| Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation. | Front Oncol | 2022 | 35311072 | PubTator, text mining | PubMed |
| Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects. | Front Immunol | 2022 | 35309357 | PubTator, text mining | PubMed |
| Cancer vaccines as promising immuno-therapeutics: platforms and current progress. | J Hematol Oncol | 2022 | 35303904 | PubTator, text mining | PubMed |
| Oncolytic Virotherapy in Peritoneal Metastasis Gastric Cancer: The Challenges and Achievements. | Front Mol Biosci | 2022 | 35295845 | PubTator, text mining | PubMed |
| Recent progress in the imaging of c-Met aberrant cancers with positron emission tomography. | Med Res Rev | 2022 | 35292998 | PubTator, text mining | PubMed |
| Type I interferon-mediated tumor immunity and its role in immunotherapy. | Cell Mol Life Sci | 2022 | 35292881 | PubTator, text mining | PubMed |
| Messenger RNA vaccines for cancer immunotherapy: progress promotes promise. | J Clin Invest | 2022 | 35289317 | PubTator, text mining | PubMed |
| On the Twentieth Anniversary of Dendritic Cell Vaccines - Riding the Next Wave. | Cancer Res | 2022 | 35288731 | PubTator, text mining | PubMed |
| Development of a prognostic nomogram based on an eight-gene signature for esophageal squamous cell carcinoma by weighted gene co-expression network analysis (WGCNA). | Ann Transl Med | 2022 | 35282133 | PubTator, text mining | PubMed |
| MAGEA1 and hTERT Peptide Treatment Improves the Potency of The Dendritic Cell- Cytotoxic T Lymphocytes (DC-CTL) Immunotherapy in DAC Treated Acute Myeloid Leukemia. | J Cancer | 2022 | 35281868 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=30